Diagnosis of infectious diseases poses a major challenge to healthcare systems worldwide. Our company has been at the forefront of IVD solutions for these diseases. We provide customized antigen, antibody and nucleic acid detection reagents/kits, along with complementary diagnostic devices to facilitate early identification of pathogens and rapid control of infections.
Overview of Infectious Disease
Infectious diseases remain a significant global health concern. These diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, and can be transmitted through various means, including direct contact, airborne particles, or contaminated surfaces. Accurate and timely diagnosis is crucial for effective therapeutics, containment, and prevention of the spread of these illnesses. However, several challenges exist in this process:
Laboratory Testing Limitations
Specialized laboratories capable of diagnosing rare infectious diseases may not be readily available in all geographic regions, leading to delays in obtaining accurate test results.
Differential Diagnosis Challenges
Rare infectious diseases may share symptoms with more prevalent conditions, making it challenging to differentiate between the two without targeted diagnostic testing.
Emerging Pathogens
The rapid mutation of pathogens, coupled with the issue of antibiotic resistance, leads to the swift evolution of sources of infection, posing challenges to accurate diagnosis.
Market Analysis of Infectious Disease Diagnostics
In 2023, the global infectious disease diagnostics market was valued at USD 30.74 billion, increasing to USD 32.99 billion in 2024. It is projected to reach around USD 66.73 billion by 2034, with a compound annual growth rate (CAGR) of 7.3% from 2024 to 2034. The adoption of point-of-care testing (POCT) devices for infectious disease diagnostics is expected to grow significantly. These portable and user-friendly devices can provide rapid diagnostics at the bedside or in remote settings, aiding in timely diagnosis and therapeutic initiation.
Fig. 1 Flow diagram showing the process of sample testing using point-of care devices. (Nath P, et al., 2020)
In Vitro Diagnostics for Infectious Diseases
In vitro diagnostics (IVD) refer to medical tests or diagnostic procedures that are performed in a controlled laboratory environment using samples such as blood, urine and other bodily fluids. Infectious disease IVDs are instrumental in precisely and promptly identifying the pathogens responsible for these illnesses. The following are some IVD kits designed for prevalent infectious diseases.
Kits |
Applications |
Detection Methods |
COVID-19 Antigen Detection Kit
|
Rapid test for COVID-19 antigen. |
Lateral Flow Immunoassay |
Hepatitis B Virus Surface Antigen Test Kit |
Qualitative detection of hepatitis B virus surface antigen (HBsAg) in human serum or plasma. |
Colloidal Gold Method |
Human Respiratory Syncytial Virus (RSV) Detection Kit |
Qualitative detection of respiratory syncytial virus (RSV) RNA. |
PCR |
HIV Antibody Test Kit |
Detection of antibodies to HIV type 1 and type 2 in whole blood, plasma, and serum. |
Immunoassay |
Our Solutions
Alta DiagnoTech stands at the forefront of clinical diagnostics, committed to delivering holistic solutions for the in vitro diagnosis of infectious diseases. Our company specializes in offering top-tier IVD reagents, kits, and advanced devices for viral, bacterial, fungal, and parasitic infections to meet your clinical diagnostic needs. With our cutting-edge point-of-care testing (POCT) products, we strive to streamline the process, enabling swift pathogen identification and timely interventions in the realm of infectious diseases.
Our IVD Solutions for Infectious Diseases
Virus Infection Detection Products
Our carefully selected virus infection testing products can rapidly and accurately detect viral pathogens, enabling timely intervention and targeted therapeutic strategies.
Fungal Infection Detection Products
Our state-of-the-art fungal infection testing products offer exceptional sensitivity and specificity, facilitating early diagnosis and personalized treatment plans for fungal infections.
Bacterial Infection Detection Products
Our bacterial infection testing products offer high diagnostic accuracy and are designed to accurately identify bacterial pathogens for effective infection management.
Parasitic Infection Detection Products
Our parasitic infection testing products detect a wide range of parasitic pathogens with high accuracy, ensuring comprehensive diagnostic capabilities to improve disease control.
Featured IVD Solutions
Respiratory Infection IVD Solutions
Liver Infection IVD Solutions
Gastrointestinal Infection IVD Solutions
Related IVD Products
Cat# |
Product Name |
Target Disease |
ALTA-3011-LJX |
COVID-19 Antigen Detection Kit |
Coronavirus Disease 2019 (COVID-19) |
ALTA-3023-LJX |
Hepatitis B Virus Surface Antigen Test Kit |
Hepatitis B |
ALTA-3029-LJX |
Human Respiratory Syncytial Virus (RSV) Detection Kit |
Respiratory Syncytial Virus Infection |
ALTA-3038-LJX |
Helicobacter Pylori Detection Kit |
Helicobacter Pylori Infection |
ALTA-3044-LJX |
HIV Antibody Test Kit |
HIV Infection/AIDS |
By leveraging state-of-the-art technologies and a commitment to excellence, our company continues to shape the landscape of infectious disease diagnostics, empowering healthcare providers and improving outcomes for patients worldwide. If you are interested in our products, please feel free to contact us for more details and quotation information.
References
- Nath P, Kabir A, Khoubafarin Doust S, et al. Detection of bacterial and viral pathogens using photonic point-of-care devices[J]. Diagnostics, 2020, 10(10): 841.
- Wang C, Liu M, Wang Z, et al. Point-of-care diagnostics for infectious diseases: From methods to devices[J]. Nano Today, 2021, 37: 101092.